Compare Lustrum:BrightPath Biotherapeutics Co., Ltd.:4594

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index BrightPath Biotherapeutics Co., Ltd. 4594 Medicals Mothers March 1, 2000 2015.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

BrightPath Biotherapeutics Co., Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2020年3月期 BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2019年3月期 BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2018年3月期 BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2017年3月期 BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2016年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016
Cash and Cash Equivalents
(Percent)
0
-
0
-
6,529up
(90.2%)down
4,951up
(91.5%)up
2,555
(88.8%)
Other Current AssetsHelp
(Percent)
3,328down
(95.8%)down
5,162up
(97.3%)up
371up
(5.1%)down
289up
(5.3%)down
236
(8.2%)
Tangible Fixed AssetsHelp
(Percent)
97up
(2.8%)up
91down
(1.7%)down
266up
(3.7%)up
116up
(2.1%)up
49
(1.7%)
Intangible Fixed AssetHelp
(Percent)
0
-
0
-
14down
(0.2%)down
14up
(0.3%)down
11
(0.4%)
Investments and OthersHelp
(Percent)
49down
(1.4%)up
52down
(1.0%)up
56up
(0.8%)up
39up
(0.7%)down
26
(0.9%)
Total AssetsHelp
(Percent)
3,475
(100%)
5,304
(100%)
7,236
(100%)
5,408
(100%)
2,877
(100%)
Total Current LiabilitiesHelp
(Percent)
239up
(6.9%)up
208down
(3.9%)down
285up
(3.9%)up
208up
(3.9%)down
157
(5.4%)
Total Long-term LiabilitiesHelp
(Percent)
0
-
0
-
0
-
0
-
0
-
Shareholder's EquityHelp
(Percent)
3,235down
(93.1%)down
5,096down
(96.1%)up
6,951up
(96.1%)down
5,200up
(96.1%)up
2,721
(94.6%)
Total LiabilitiesHelp
(Percent)
3,475
(100%)
5,304
(100%)
7,236
(100%)
5,408
(100%)
2,877
(100%)

BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2020年3月期 BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2019年3月期 BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2018年3月期 BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2017年3月期 BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2016年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016
Amount of Sales
(Percent)
11
(100%)
156
(100%)
354
(100%)
530
(100%)
823
(100%)
Total Sales
(Percent)
11
(100%)
156
(100%)
354
(100%)
530
(100%)
823
(100%)
Cost of SalesHelp
(Percent)
4down
(39.5%)down
71down
(45.4%)down
315down
(89.0%)down
525down
(99.1%)up
772
(93.8%)
Other Costs and RevenueHelp 1,865down
(16,500.9%)up
1,969up
(1,264.0%)up
1,616up
(456.4%)up
1,118up
(211.2%)up
1,045
(127.1%)
Total CostsHelp 1,869 2,040 1,931 1,643 1,817
Net RevenueHelp 7down
(60.5%)up
85up
(54.6%)up
39up
(11.0%)up
5down
(0.9%)down
51
(6.2%)
Earnings Before TaxHelp -1,860up
(-16,458.9%)down
-1,881down
(-1,207.0%)down
-1,573down
(-444.4%)down
-1,117down
(-210.9%)down
-993
(-120.7%)
Net IncomeHelp -1,858up
(-16,440.5%)down
-1,884down
(-1,209.4%)down
-1,577down
(-445.5%)down
-1,114down
(-210.3%)down
-994
(-120.9%)
当期純利益 -1,858 -1,884 -1,577 -1,114 -994

BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2020年3月期 BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2019年3月期 BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2018年3月期 BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2017年3月期 BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2016年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016
Operating Cash Flow(OFC)Help
(Percent)
-1,784down
(-94.3%)down
-1,458up
(-88.7%)down
-1,591down
(-48.5%)down
-1,068down
(-30.0%)up
-909
(-34.0%)
Investing Cash Flow(ICF)Help
(Percent)
-107up
(-5.7%)up
-185down
(-11.3%)down
-112down
(-3.4%)down
-97down
(-2.7%)down
-32
(-1.2%)
Financing Cash FlowHelp
(Percent)
9down
(0.5%)down
16down
(1.0%)down
3,281down
(100.0%)
3,559up
(100.0%)
2,673
(100.0%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
0up
(0.0%)up
-0
(0.0%)
0
-
-0
(0.0%)
0
-
Net Increase and Decrease in Cash and Cash Equivalentsn -1,883down
(-99.5%)down
-1,627down
(-99.0%)down
1,578down
(48.1%)down
2,395up
(67.3%)up
1,732
(64.8%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

BrightPath Biotherapeutics Co., Ltd.

Company where related level is highHelp

Daito Pharmaceutical Co.,Ltd.
Immuno-Biological Laboratories Co., Ltd.
WAKAMOTO PHARMACEUTICAL CO.,LTD.
BrightPath Biotherapeutics Co., Ltd.
D.Western Therapeutics Institute, Inc.
Sanko Junyaku Co.,Ltd.
CanBas Co.,Ltd.
KAKEN PHARMACEUTICAL CO.,LTD.
HISAMITSU PHARMACEUTICAL CO.,INC.
TOWA PHARMACEUTICAL CO.,LTD.